Pankaj Kumar

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer

Daniel V.T. Catenacci, Melissa R. Junttila, Theodore Karrison et al. · Journal of Clinical Oncology · 2015 · 544 citations

Medicine, Oncology, Pharmacology +17

Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial

Shaji Kumar, Susanna Jacobus, Adam D. Cohen et al. · The Lancet Oncology · 2020 · 253 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer

Jeffrey A. Meyerhardt, Qian Shi, Charles S. Fuchs et al. · JAMA · 2021 · 130 citations · Full text

Medicine, Oncology, Pharmacology +16

Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)☆

Romain Cohen, J. Meyers, Zhe Jin et al. · Annals of Oncology · 2021 · 122 citations · Full text

Medicine, Oncology, Surgery +17

Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer

En Cheng, Qian Shi, Anthony F. Shields et al. · JAMA Oncology · 2023 · 43 citations · Full text

Medicine, Immunology, Oncology +17